Human Milk Fortification in Extremely Preterm Infants

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

January 31, 2029

Conditions
Necrotizing EnterocolitisSepsisMortality
Interventions
DIETARY_SUPPLEMENT

H2MF

H2MF is a human milk-based breastmilk fortifier for preterm infants

DIETARY_SUPPLEMENT

Bovine milk-based fortifier

Bovine milk-based fortifier is the standard breast milk fortifier in Sweden

Trial Locations (5)

Unknown

Queen Silvia Children´s Hospital, Gothenburg

Crown Princess Victoria Children´s Hospital, Linköping

Karolinska Hospital, Stockholm

Norrlands Universitetssjukhus, Umeå

Akademiska Barnsjukhuset, Uppsala

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Region Uppsala

UNKNOWN

collaborator

Vasterbottens lans landsting

UNKNOWN

collaborator

Prolacta Bioscience

INDUSTRY

collaborator

Region Stockholm

OTHER_GOV

lead

Thomas Abrahamsson, MD, PhD

OTHER

NCT03797157 - Human Milk Fortification in Extremely Preterm Infants | Biotech Hunter | Biotech Hunter